GC MediAI, a company specializing in AI-based medical operating systems, announced on Monday that it has officially provided annual operating profit guidance for the first time since its founding. The company set a target of 13.5 billion KRW (about 9 million USD) for consolidated operating profit in 2026, representing an 80% increase from the previous year’s 7.5 billion KRW (about 5 million USD).
Over the past three years, GC MediAI has consistently improved its profitability. The company anticipates further expansion of its growth structure this year, as new artificial intelligence (AI) and platform-based revenue streams complement its already robust core business.
In 2025, GC MediAI reported consolidated revenue of 197.7 billion KRW (about 132 million USD) and operating profit of 7.5 billion KRW (about 5 million USD), marking a 45.7% year-over-year increase in operating profit. The company’s operating profit margin has shown steady improvement over the last three years.
GC MediAI has built its revenue structure around five key business areas: electronic medical record (EMR) solutions for healthcare providers, medical infrastructure, pharmaceutical data and marketing, medical supply distribution, and a digital healthcare platform with a commission-based model.
The medical infrastructure sector, maintaining an operating profit margin exceeding 20%, serves as the backbone of the company’s overall performance. Meanwhile, the data and marketing sector continues to achieve high profitability in the 30% range. In the platform sector, the paid membership for the telemedicine platform Ddoc has surpassed 1 million subscribers, maintaining strong growth momentum.
This year, GC MediAI expects its profitability to improve further as it expands its AI and platform-based operations alongside stable growth in existing businesses. The company plans to enhance profitability in its medical infrastructure and data/marketing sectors by increasing average transaction values and expanding AI services. The platform sector aims to strengthen its commission-based business model through expanded partnerships in digital healthcare.
The company has identified DoctorAI as a key driver for future growth, with its official launch scheduled for next month. DoctorAI is an AI-powered automation solution supporting the entire medical consultation process, including automatic documentation (speech-to-text), AI-assisted prescriptions, and clinical decision support.
Kim Jin-tae, Chief Executive Officer (CEO) of GC MediAI, stated that this year marks the beginning of the new revenue structure centered on AI and platforms, built upon the stable existing revenue base. Moving forward, GC MediAI will evolve into an AI-based medical operating system company that connects the entire healthcare ecosystem.
GC MediAI is the rebranded name of the former UbiCare, adopted to unify the brand among GC Group’s digital healthcare subsidiaries and to reflect its expanded focus on AI-based healthcare solutions.